269 related articles for article (PubMed ID: 36159808)
21. Genetic characteristics and clinical-specific survival prediction in elderly patients with gallbladder cancer: a genetic and population-based study.
Zhou H; Chen J; Jin H; Liu K
Front Endocrinol (Lausanne); 2023; 14():1159235. PubMed ID: 37152947
[TBL] [Abstract][Full Text] [Related]
22. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients.
Xia C; Huang W; Chen YL; Fu HB; Tang M; Zhang TL; Li J; Lv GH; Yan YG; Ouyang ZH; Yao N; Wang C; Zou MX
Front Immunol; 2021; 12():797407. PubMed ID: 35145510
[TBL] [Abstract][Full Text] [Related]
24. HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
Huang FX; Wu JW; Cheng XQ; Wang JH; Wen XZ; Li JJ; Zhang Q; Jiang H; Ding QY; Zhu XF; Zhang XS; Ding Y; Li DD
Front Immunol; 2022; 13():902167. PubMed ID: 36003385
[TBL] [Abstract][Full Text] [Related]
25. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.
Cheng H; Borczuk A; Janakiram M; Ren X; Lin J; Assal A; Halmos B; Perez-Soler R; Zang X
Clin Cancer Res; 2018 Apr; 24(8):1954-1964. PubMed ID: 29374053
[No Abstract] [Full Text] [Related]
26. Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes.
Kim NI; Park MH; Cho N; Lee JS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):246-256. PubMed ID: 35384874
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.
Yang J; Tian Z; Gao H; Xiong F; Cao C; Yu J; Shi W; Zhan Q; Yang C
BMC Cancer; 2022 May; 22(1):584. PubMed ID: 35624419
[TBL] [Abstract][Full Text] [Related]
28. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.
Chen LJ; Sun J; Wu HY; Zhou SM; Tan Y; Tan M; Shan BE; Lu BF; Zhang XG
Cancer Immunol Immunother; 2011 Jul; 60(7):1047-55. PubMed ID: 21519829
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of HHLA2 and CD8 Immunohistochemical Expression in Colorectal Carcinoma and Their Prognostic Significance.
Gawesh ZM; Ibrahim EM; ElKalla HMHR; Awad AAH; Mohamed MA
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4309-4319. PubMed ID: 38156868
[TBL] [Abstract][Full Text] [Related]
30. Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration.
Kim NI; Park MH; Lee JS
Appl Immunohistochem Mol Morphol; 2020; 28(10):767-775. PubMed ID: 31714284
[TBL] [Abstract][Full Text] [Related]
31. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
[No Abstract] [Full Text] [Related]
32. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
Zhao R; Chinai JM; Buhl S; Scandiuzzi L; Ray A; Jeon H; Ohaegbulam KC; Ghosh K; Zhao A; Scharff MD; Zang X
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9879-84. PubMed ID: 23716685
[TBL] [Abstract][Full Text] [Related]
33. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
[TBL] [Abstract][Full Text] [Related]
34. HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.
Cheng H; Janakiram M; Borczuk A; Lin J; Qiu W; Liu H; Chinai JM; Halmos B; Perez-Soler R; Zang X
Clin Cancer Res; 2017 Feb; 23(3):825-832. PubMed ID: 27553831
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a nomogram prediction model based on albumin-to-alkaline phosphatase ratio for predicting the prognosis of gallbladder carcinoma.
Fan Z; Liu B; Shang P
Pathol Oncol Res; 2022; 28():1610818. PubMed ID: 36685104
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
37. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
38. HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival.
Koirala P; Roth ME; Gill J; Chinai JM; Ewart MR; Piperdi S; Geller DS; Hoang BH; Fatakhova YV; Ghorpade M; Zang X; Gorlick R
Sci Rep; 2016 Aug; 6():31154. PubMed ID: 27531281
[TBL] [Abstract][Full Text] [Related]
39. The Importance of HHLA2 in Solid Tumors-A Review of the Literature.
Kula A; Koszewska D; Kot A; Dawidowicz M; Mielcarska S; Waniczek D; Świętochowska E
Cells; 2024 May; 13(10):. PubMed ID: 38786018
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma.
Chen L; Zhou B; Tang M; Yao Y; Zhao Y; Hu Y; Lin Y; Ji J; Jiao Q
Arch Dermatol Res; 2024 Jun; 316(7):382. PubMed ID: 38850312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
